302 related articles for article (PubMed ID: 16338206)
21. ELISA subtypization of anti-ENA autoantibodies in clinical management of autoimmune diseases in Bosnia and Herzegovina.
Subasic D; Karamehic J; Gavrankapetanovic F; Hodzic H; Kasumovic M; Delic-Sarac M; Prljaca-Zecevic L
Med Arh; 2009; 63(6):312-6. PubMed ID: 20380108
[TBL] [Abstract][Full Text] [Related]
22. Increased titres of anti-nuclear antibodies do not predict the development of associated disease in the absence of initial suggestive signs and symptoms.
Dinser R; Braun A; Jendro MC; Engel A
Scand J Rheumatol; 2007; 36(6):448-51. PubMed ID: 18092266
[TBL] [Abstract][Full Text] [Related]
23. Detection and identification of significant ANAs in previously determined ANA negative samples.
Kidd K; Cusi K; Mueller R; Goodner M; Boyes B; Hoy E
Clin Lab; 2005; 51(9-10):517-21. PubMed ID: 16285474
[TBL] [Abstract][Full Text] [Related]
24. Testing for antibodies to ENA and to dsDNA is not indicated in FANA-negative sera.
Manoussakis MN; Garalea KL; Tzioufas AG; Moutsopoulos HM
Clin Rheumatol; 1988 Dec; 7(4):465-9. PubMed ID: 3073034
[TBL] [Abstract][Full Text] [Related]
25. [Detection of anti-ENA and anti-dsDNA antibodies using line immunoassay in systemic autoimmune diseases].
Kim JM; Ihm CH; Sin DH; Ihm MK; Sim SC
Korean J Lab Med; 2008 Oct; 28(5):353-61. PubMed ID: 18971616
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice.
Ulvestad E; Kanestrøm A; Madland TM; Thomassen E; Haga HJ; Vollset SE
Scand J Immunol; 2000 Sep; 52(3):309-15. PubMed ID: 10972909
[TBL] [Abstract][Full Text] [Related]
27. Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies.
Kang I; Siperstein R; Quan T; Breitenstein ML
Clin Rheumatol; 2004 Dec; 23(6):509-15. PubMed ID: 15801070
[TBL] [Abstract][Full Text] [Related]
28. [The clinical immunology laboratory in diagnosis and monitoring of systemic lupus erythematosus and connective tissue diseases].
Sinico RA; Radice A
G Ital Nefrol; 2005; 22 Suppl 33():S21-6. PubMed ID: 16419001
[TBL] [Abstract][Full Text] [Related]
29. [Anti-ENA antibody determination in various connective tissue diseases: comparison of 2 detection techniques].
Vaccai D; Cataldi V; Morozzi G; Bacarelli MR; Ciali A; Pucci G; Marcolongo R
Boll Soc Ital Biol Sper; 1993 Jan; 69(1):45-8. PubMed ID: 8329190
[TBL] [Abstract][Full Text] [Related]
30. Comparison of three multiplex immunoassays for detection of antibodies to extractable nuclear antibodies using clinically defined sera.
Copple SS; Martins TB; Masterson C; Joly E; Hill HR
Ann N Y Acad Sci; 2007 Aug; 1109():464-72. PubMed ID: 17785335
[TBL] [Abstract][Full Text] [Related]
31. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
Myckatyn SO; Russell AS
J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
[TBL] [Abstract][Full Text] [Related]
32. Dense fine speckled indirect immunofluorescence pattern in an Australian population.
Broadfoot A; Sivertsen T; Baumgart K
Pathology; 2016 Apr; 48(3):247-50. PubMed ID: 27020500
[TBL] [Abstract][Full Text] [Related]
33. The relationship between antinuclear antibody data and antibodies against extractable nuclear antigens in a large laboratory cohort.
Craig WY; Ledue TB
Clin Chem Lab Med; 2011 Nov; 50(3):497-502. PubMed ID: 22098438
[TBL] [Abstract][Full Text] [Related]
34. Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years.
Selmi C; Ceribelli A; Generali E; Scirè CA; Alborghetti F; Colloredo G; Porrati L; Achenza MI; De Santis M; Cavaciocchi F; Massarotti M; Isailovic N; Paleari V; Invernizzi P; Matthias T; Zucchi A; Meroni PL
Autoimmun Rev; 2016 Feb; 15(2):162-6. PubMed ID: 26524640
[TBL] [Abstract][Full Text] [Related]
35. Epidermal nuclear immunoglobulin deposition in connective tissue diseases.
Rodrigues CJ; de Oliveira RM; Taniwaki NN; Bueno C; Marchiori P; Cossermelli W
Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(4):154-7. PubMed ID: 2135825
[TBL] [Abstract][Full Text] [Related]
36. Autoantibody detection with indirect immunofluorescence on HEp-2 cells: starting serum dilutions for systemic rheumatic diseases.
González DA; León AC; Varela AR; García MG; Rahola Mde S; Pérez Mdel C; Hernández AG; Falcón MJ; Díaz BB
Immunol Lett; 2011 Oct; 140(1-2):30-5. PubMed ID: 21684306
[TBL] [Abstract][Full Text] [Related]
37. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
Tipu HN; Bashir MM
J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
[TBL] [Abstract][Full Text] [Related]
38. [Determination of non-organ specific autoantibodies. Their relevance for the differentiation of autoimmune diseases].
Blaschek MA
Wien Med Wochenschr; 1987 Jul; 137(13):295-301. PubMed ID: 3307167
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic utility of unidentified precipitin lines (UPLs) in immune precipitation assays.
Pajaro A; Nikoloutsopoulos T; Roberts-Thomson P
Pathology; 2015 Jan; 47(1):62-7. PubMed ID: 25474508
[TBL] [Abstract][Full Text] [Related]
40. [Use of autoantibodies in clinical practice].
Petitpierre S; Aubert V; Leimgruber A; Spertini F; Bart PA
Rev Med Suisse; 2009 Apr; 5(199):823-31. PubMed ID: 19441748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
